Table 3. Sensitivity analysis using macrolide as an active comparator.

	Effect estimate adjusted by disease risk score (RR, 95% confidence interval)
Current fluoroquinolone use (1–60 day)	1.90 (1.62–2.22)***
Current macrolide use (1–60 day)	1.11 (0.15–7.99)

*** refers to p<0.001

RR refers to rate ratio.